We engineer the molecules of tomorrow — designing next-generation therapeutics and synthetic enzymes with novel catalytic functions, through the fusion of atomistic precision and data-driven intelligence.
We advance data-driven molecular design as a platform for solving unmet global challenges — coupling automation, structural insight, and molecular-level understanding to accelerate solutions in human health, sustainable catalysis, and infectious disease. Our group cultivates an environment where rigorous science and bold ideas converge.
Design and evaluation of next-generation inhibitors targeting antimicrobial resistance.
Learn more →
Engineering nature-inspired biocatalysts and new synthetic enzymes with novel functions.
Learn more →
Developing next-generation computational methods to accelerate chemical discovery.
Learn more →
Decoding reaction mechanisms and catalytic processes to guide rational synthetic design.
Learn more →Awarded a prestigious Liverpool University Research Fellowship to start his own research group at the University of Liverpool.
Our work on the CDIN1-Codanin-1 complex — defective in Congenital Dyserythropoietic Anaemia Type I — has been accepted in Nature Communications.
Read Paper →Interested in collaboration, PhD opportunities, or joining the group? We'd love to hear from you.